Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Assembly Biosciences (ASMB) over the last 11 years, with Q3 2025 value amounting to $3.3 million.

  • Assembly Biosciences' Prepaid Assets rose 257.75% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 257.75%. This contributed to the annual value of $3.4 million for FY2024, which is 208.75% down from last year.
  • As of Q3 2025, Assembly Biosciences' Prepaid Assets stood at $3.3 million, which was up 257.75% from $2.5 million recorded in Q2 2025.
  • In the past 5 years, Assembly Biosciences' Prepaid Assets registered a high of $7.3 million during Q1 2022, and its lowest value of $2.5 million during Q2 2025.
  • Moreover, its 5-year median value for Prepaid Assets was $4.4 million (2022), whereas its average is $4.9 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first soared by 4332.31% in 2021, then tumbled by 4481.78% in 2023.
  • Assembly Biosciences' Prepaid Assets (Quarter) stood at $7.2 million in 2021, then crashed by 39.06% to $4.4 million in 2022, then dropped by 20.76% to $3.5 million in 2023, then fell by 2.09% to $3.4 million in 2024, then dropped by 2.37% to $3.3 million in 2025.
  • Its Prepaid Assets stands at $3.3 million for Q3 2025, versus $2.5 million for Q2 2025 and $4.5 million for Q1 2025.